⌘K

Login Start Free

Home/Filings/4/0001144204-17-031102

4//SEC Filing

EYEGATE PHARMACEUTICALS INC 4

Accession 0001144204-17-031102

$KPRXCIK 0001372514operating

View on SEC.gov Company Profile

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 7:41 PM ET

Size

6.9 KB

Accession

0001144204-17-031102

Insider Transaction Report

Form 4

Period: 2017-06-02

EYEGATE PHARMACEUTICALS INCEYEG

Director

Transactions

Exercise/Conversion
Common Stock
2017-06-02$0.65/sh+17,570$11,421→ 41,229 total
Exercise/Conversion
Stock Option (right to buy)
2017-06-02−17,570→ 0 total
Exercise: $0.65Exp: 2017-07-17→ Common Stock (17,570 underlying)

Footnotes (1)

[F1]The reporting person was granted an option to purchase these shares pursuant to the Issuer's 2005 Equity Incentive Plan. The option became exercisable immediately at the time of grant.

Documents

1 file

4
v468441_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

EYEGATE PHARMACEUTICALS INC

CIK 0001372514

Entity typeoperating

Related Parties

1

filerCIK 0001372514

Filing Metadata

Form type: 4
Filed: Jun 4, 8:00 PM ET
Accepted: Jun 5, 7:41 PM ET
Size: 6.9 KB

View on SEC.gov